

PRODUCT DESCRIPTION
- Contents : Cross-linked HA
- Volume : 10mL / syringe
- Concentration : 20mg / mL
- Injection Force (Visco-elasticity) : 49.0 ~ 51.5 N
- Recommended area : Breast and Buttock
MDM patented technology (MBMT + DMCT + MDAP)
MBMT (Micro Bead Monophasic Technology)
Enable the worlds largest Viscoelasticity by microbeading of the HA (Hyaluronic Acid) and maintaining Monophasic properties.
DMCT (Divinyl sulfone Multi-Crosslink Technology)
Multi-crosslinking of HA (Hyaluronic Acid) with DVS crosslinking agent. A technology to implement complete crosslinking.
MDAP (Multiple Degree Amphiphilic Purification)
Technology that improves safety and produces the highest purity products by refining crosslinked microbeads in multiple times.
Long lasting
Molding ability : Strong
Final type : Monophasic (Gel Only)
Appearance : Transparent, colorless gel
Certification : KGMP / ISO13485 / CE(2195) / MDSAP
Micro particles of Dene-B shows high cohesiveness and provides safety and long-lasting effect without altering its chemical properties.